Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:44-52

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benetos, A.
Right arrow Articles by Guize, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benetos, A.
Right arrow Articles by Guize, L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Other hypertension
Right arrow Epidemiology

(Hypertension. 1999;33:44-52.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Influence of Heart Rate on Mortality in a French Population

Role of Age, Gender, and Blood Pressure

Athanase Benetos; Annie Rudnichi; Frédérique Thomas; Michel Safar; Louis Guize

From the Investigations Préventives et Cliniques (IPC) (A.B., A.R., F.T., L.G.) and INSERM U337 (A.B., M.S.), Paris, France.

Abstract—The aim of the present study was to assess the effects of high heart rate on mortality in different subgroups in a French population according to age, gender, and blood pressure levels. We studied 19 386 subjects (12 123 men, 7263 women), aged 40 to 69 years, who had a routine health examination at the Centre d'Investigations Préventives et Cliniques (IPC) between 1974 and 1977. Heart rate (HR) measured by ECG was classified into 4 groups: HR1, <60; HR2, 60 to 80; HR3, 81 to 100; and HR4, >100 bpm. Mortality data were recorded for the period of 1974 through 1994. In both sexes, HR was a significant predictor of noncardiovascular mortality. In men, the relative risk (95% confidence interval) for cardiovascular death after adjustment for age and other risk factors in the HR2, HR3, and HR4 groups was 1.35 (1.01 to 1.80), 1.44 (1.04 to 2.00), and 2.18 (1.37 to 3.47), respectively, when compared with HR1. In women, HR did not influence cardiovascular mortality. The association of HR with cardiovascular mortality in men was (1) related to a strong association with coronary but not cerebrovascular mortality, (2) independent of age and hypertension, and (3) influenced by the level of pulse pressure; in patients with high pulse pressure (>65 mm Hg), accelerated HR was not associated with increased cardiovascular mortality. In conclusion, in a large French population, accelerated resting HR represents an independent predictor of noncardiovascular mortality in both genders, and of cardiovascular mortality in men, independent of age and the presence of hypertension. Further investigations are needed to explain the complex interactions between HR, pulse pressure, and cardiovascular complications.


Key Words: mortality • heart rate • pulse pressure • coronary artery disease • cerebrovascular disorders




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Beddhu, S. U. Nigwekar, X. Ma, and T. Greene
Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease
Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2482 - 2488.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
J.-C. Tardif
Heart rate and atherosclerosis
Eur. Heart J. Suppl., August 1, 2009; 11(suppl_D): D8 - D12.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
P. G. Steg
Heart rate management in coronary artery disease: the CLARIFY registry
Eur. Heart J. Suppl., August 1, 2009; 11(suppl_D): D13 - D18.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Biel, C. Wahl-Schott, S. Michalakis, and X. Zong
Hyperpolarization-Activated Cation Channels: From Genes to Function
Physiol Rev, July 1, 2009; 89(3): 847 - 885.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Bohm, M. Thoenes, H.-R. Neuberger, S. Graber, J.-C. Reil, P. Bramlage, and M. Volpe
Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients
Eur. Heart J., June 1, 2009; 30(11): 1364 - 1371.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
J.-C. Tardif
Heart rate as a treatable cardiovascular risk factor
Br. Med. Bull., June 1, 2009; 90(1): 71 - 84.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Tverdal, V. Hjellvik, and R. Selmer
Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379 843 men and women aged 40-45 years
Eur. Heart J., November 2, 2008; 29(22): 2772 - 2781.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Bangalore, S. Sawhney, and F. H. Messerli
Relation of Beta-Blocker-Induced Heart Rate Lowering and Cardioprotection in Hypertension
J. Am. Coll. Cardiol., October 28, 2008; 52(18): 1482 - 1489.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
B. L. Sprague, A. Trentham-Dietz, B. E.K. Klein, R. Klein, K. J. Cruickshanks, K. E. Lee, and J. M. Hampton
Physical Activity, White Blood Cell Count, and Lung Cancer Risk in a Prospective Cohort Study
Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2714 - 2722.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
R. M. Carney, B. Steinmeyer, K. E. Freedland, J. A. Blumenthal, P. K. Stein, W. A. Steinhoff, W. B. Howells, L. F. Berkman, L. L. Watkins, S. M. Czajkowski, et al.
Nighttime Heart Rate and Survival in Depressed Patients Post Acute Myocardial Infarction
Psychosom Med, September 1, 2008; 70(7): 757 - 763.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
J.-C. Tardif
The pivotal role of heart rate in clinical practice: from atherosclerosis to acute coronary syndrome
Eur. Heart J. Suppl., August 1, 2008; 10(suppl_F): F11 - F16.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. W. Hansen, L. Thijs, J. Boggia, Y. Li, M. Kikuya, K. Bjorklund-Bodegard, T. Richart, T. Ohkubo, J. Jeppesen, C. Torp-Pedersen, et al.
Prognostic Value of Ambulatory Heart Rate Revisited in 6928 Subjects From 6 Populations
Hypertension, August 1, 2008; 52(2): 229 - 235.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A S Hall and S Palmer
The heart rate hypothesis: ready to be tested
Heart, May 1, 2008; 94(5): 561 - 565.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Cucherat
Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials
Eur. Heart J., December 2, 2007; 28(24): 3012 - 3019.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
O Rogowski, I Shapira, A Shirom, S Melamed, S Toker, and S Berliner
Heart rate and microinflammation in men: a relevant atherothrombotic link
Heart, August 1, 2007; 93(8): 940 - 944.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al.
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Eur. Heart J., June 11, 2007; (2007) ehm236v1.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
C. Funck-Brentano and B. Charbit
Prolonged ventricular repolarization in hypertension: is it heart rate?
Arch Intern Med, October 23, 2006; 166(19): 2157 - 2157.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S. Cook, M. Togni, M. C. Schaub, P. Wenaweser, and O. M. Hess
High heart rate: a cardiovascular risk factor?
Eur. Heart J., October 2, 2006; 27(20): 2387 - 2393.
[Full Text] [PDF]


Home page
StrokeHome page
R. Cumurciuc, P. Henry, C. Gobron, E. Vicaut, M.-G. Bousser, H. Chabriat, and K. Vahedi
Electrocardiogram in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Patients Without Any Clinical Evidence of Coronary Artery Disease: A Case-Control Study
Stroke, April 1, 2006; 37(4): 1100 - 1102.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. P. Savonen, T. A. Lakka, J. A. Laukkanen, P. M. Halonen, T. H. Rauramaa, J. T. Salonen, and R. Rauramaa
Heart rate response during exercise test and cardiovascular mortality in middle-aged men
Eur. Heart J., March 1, 2006; 27(5): 582 - 588.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
K. Fox
Future perspectives of If inhibition in various cardiac conditions
Eur. Heart J. Suppl., September 1, 2005; 7(suppl_H): H33 - H36.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Hemingway, M. Shipley, E. Brunner, A. Britton, M. Malik, and M. Marmot
Does Autonomic Function Link Social Position to Coronary Risk?: The Whitehall II Study
Circulation, June 14, 2005; 111(23): 3071 - 3077.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Palatini
Heart rate: a strong predictor of mortality in subjects with coronary artery disease
Eur. Heart J., May 2, 2005; 26(10): 943 - 945.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. Diaz, M. G. Bourassa, M.-C. Guertin, and J.-C. Tardif
Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease
Eur. Heart J., May 2, 2005; 26(10): 967 - 974.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Biagini, A. Elhendy, J. J. Bax, V. Rizzello, A. F.L. Schinkel, R. T. van Domburg, M. D. Kertai, B. J. Krenning, M. Bountioukos, C. Rapezzi, et al.
Seven-year follow-up after dobutamine stress echocardiography: Impact of gender on prognosis
J. Am. Coll. Cardiol., January 4, 2005; 45(1): 93 - 97.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Lacolley
Mechanical influence of cyclic stretch on vascular endothelial cells
Cardiovasc Res, September 1, 2004; 63(4): 577 - 579.
[Full Text] [PDF]


Home page
ChestHome page
S. R. Salpeter, T. M. Ormiston, and E. E. Salpeter
Cardiovascular Effects of {beta}-Agonists in Patients With Asthma and COPD: A Meta-Analysis
Chest, June 1, 2004; 125(6): 2309 - 2321.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. Palatini, L. Thijs, J. A. Staessen, R. H. Fagard, C. J. Bulpitt, D. L. Clement, P. W. de Leeuw, M. Jaaskivi, G. Leonetti, C. Nachev, et al.
Predictive Value of Clinic and Ambulatory Heart Rate for Mortality in Elderly Subjects With Systolic Hypertension
Arch Intern Med, November 11, 2002; 162(20): 2313 - 2321.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. N. Singh
Morbidity and Mortality in Cardiovascular Disorders: Impact of Reduced Heart Rate
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2001; 6(4): 313 - 331.
[PDF]


Home page
AJPHHome page
F. Seccareccia, F. Pannozzo, F. Dima, A. Minoprio, A. Menditto, C. Lo Noce, and S. Giampaoli
Heart Rate as a Predictor of Mortality: The MATISS Project
Am J Public Health, August 1, 2001; 91(8): 1258 - 1263.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Benetos, C. Adamopoulos, J.-M. Bureau, M. Temmar, C. Labat, K. Bean, F. Thomas, B. Pannier, R. Asmar, M. Zureik, et al.
Determinants of Accelerated Progression of Arterial Stiffness in Normotensive Subjects and in Treated Hypertensive Subjects Over a 6-Year Period
Circulation, March 12, 2002; 105(10): 1202 - 1207.
[Abstract] [Full Text] [PDF]